Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Knowing when to rebalance keeps your retirement plan on track. This intro covers indicators and a simple action plan.
17,694 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Two leveraged gold bets, DGP and UGL, jump with gold but carry different risk profiles. This analysis explains the st...
A tech giant lanes three high-margin engines—cloud, ads, and subscriptions—on a profitable retail base, challenging m...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
Alphabet’s cloud momentum is reshaping the risk-and-reward profile for investors. This article explains why the googl...
If you want access to the credit card bonus points best options, you need a smart, methodical plan. This guide breaks...
REX Shares launches a new wave of ETF products focused on income, leverage, crypto, and thematic strategies to meet d...
SCHD will conduct its annual reconstitution on March 23, trimming energy exposure and leaning more on financials to d...
Crypto markets are cooling as macro policy tightens and Bitcoin stalls on a breakout. This combination has led to a d...
Karman Space & Defense reported a solid quarter, but its stock slipped. This article breaks down the factors behind t...
NVIDIA just raised dividend marks a bold shift in capital allocation as AI demand surges. This guide breaks down what...
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...